Doyle Mittie
Chief Medical Officer
Doyle Mittie has filed 15 SEC Form 4 filings (37 transaction rows) across 1 company, with disclosures dating back to 2025. 15 of those filings fall inside the rolling window. Most recent filing: Sep 1, 2026.
On the most recent filing, Doyle Mittie is listed as Chief Medical Officer at Avalo Therapeutics, Inc. Inside the rolling window, Doyle Mittie reported no open-market purchases and 13 open-market sales totaling $3.0M in AVTX. The largest disclosed transaction in the window is a sale of 106,555 AVTX shares on May 6, 2026, worth $2.2M.
Companies traded
Other insiders at AVTX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$3.0M
reported sales (SEC code S)
Companies
1
in the rolling window
| Source | |||||||
|---|---|---|---|---|---|---|---|
| AVTX | Chief Medical Officer | Sale | 679 | $14K | Sep 1 | SEC ↗ | |
| AVTX | Chief Medical Officer | Sale | 1,000 | $20K | Aug 19 | SEC ↗ | |
| AVTX | Chief Medical Officer | Sale | 679 | $14K | Aug 12 | SEC ↗ | |
| AVTX | Chief Medical Officer | Sale | 1,000 | $20K | Jul 29 | SEC ↗ | |
| AVTX | Chief Medical Officer | Sale | 4,654 | $93K | Jul 2 | SEC ↗ | |
| AVTX | Chief Medical Officer | Sale | 1,450 | $26K | Jun 25 | SEC ↗ | |
| AVTX | Chief Medical Officer | Sale | 679 | $11K | Jun 1 | SEC ↗ | |
| AVTX | Chief Medical Officer | Sale | 3,000 | $56K | May 19 | SEC ↗ | |
| AVTX | Chief Medical Officer | Sale | 1,679 | $27K | May 7 | SEC ↗ | |
| AVTX | Chief Medical Officer | Sale | 106,555 | $2.2M | May 7 | SEC ↗ | |
| AVTX | Chief Medical Officer | Sale | 3,970 | $72K | Apr 8 | SEC ↗ | |
| AVTX | Chief Medical Officer | Sale | 679 | $11K | Apr 3 | SEC ↗ | |
| AVTX | Chief Medical Officer | Sale | 25,492 | $412K | Mar 18 | SEC ↗ |
Frequently asked questions
How many SEC Form 4 filings has Doyle Mittie made?
Doyle Mittie has filed 15 SEC Form 4 filings (37 transaction rows) across 1 company since 2025.
Which companies does Doyle Mittie trade?
Doyle Mittie has filed SEC Form 4 disclosures for 1 company, including AVTX.
When was Doyle Mittie's most recent SEC Form 4 filing?
Doyle Mittie's most recent SEC Form 4 filing on Tracefour is dated Sep 1, 2026.
What is Doyle Mittie's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Doyle Mittie is listed as Chief Medical Officer.
What is Doyle Mittie's total buy and sell value in the current window?
Inside the rolling retention window, Doyle Mittie bought $0 and sold $3.0M based on SEC Form 4 filings.
What was Doyle Mittie's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 106,555 AVTX shares on 2026-05-06, worth $2.2M, per SEC Form 4 filings.